Phaseline

Companies › PT. Prodia Stem Cell Indonesia

PT. Prodia Stem Cell Indonesia: clinical trials, targets and expected readouts

6 active drug programs in 11 registered trials: 10 Phase 1, 1 Phase 2; Respiratory, Oncology, Neurology, Immunology; next expected readout Dec 2026.

Open in Phaseline: competitors, likelihood bands and readouts Company report

Programs

DrugTargetHighest phaseConditionsNext expected readout
Conditioned Medium
Intranasal secretome from mesenchymal stem cells
–Phase 1Ischemic Stroke; Cerebral PalsyDec 2026
UC-MSC and Secretome
Umbilical cord mesenchymal stem cells combined with conditioned medium (secretome)
–Phase 1Androgenetic Alopecia; Acute Respiratory Distress SyndromeDec 2026
Umbilical Cord Mesenchymal Stem Cells (UC-MSCs)
Intraparenchymal transplantation of mesenchymal stromal cells for neurogenesis
–Phase 1Ischemic Stroke; Cerebral Palsy; Diabetic Nephropathy Type 2; Chronic Obstructive Pulmonary Disease (COPD)Dec 2026
Umbilical Cord-Mesenchymal Stem Cell (UC-MSC)
Mesenchymal stem cells derived from umbilical cord tissue
–Phase 1Acute Respiratory Distress SyndromeDec 2026
Allo-Dendritic Cell-Secretome (Allogeneic Dendritic Cell-Secretome)
Allogeneic dendritic cell secretome therapy
–Phase 1Nasopharyngeal Cancer–
Auto-DC (Autologous Dendritic Cell)
Autologous dendritic cell therapy
–Phase 1Nasopharyngeal Cancer–

Trials

Registry idDrugPhaseConditionsAreaExpected readout
NCT05261750Auto-DC (Autologous Dendritic Cell)Phase 1Nasopharyngeal CancerOncologyFeb 2026
NCT05261750Allo-Dendritic Cell-Secretome (Allogeneic Dendritic Cell-Secretome)Phase 1Nasopharyngeal CancerOncologyFeb 2026
NCT05008588Umbilical Cord Mesenchymal Stem Cells (UC-MSCs)Phase 1Ischemic StrokeNeurologyMar 2026
NCT05008588Conditioned MediumPhase 1Ischemic StrokeNeurologyMar 2026
NCT07429253UC-MSC and SecretomePhase 1Androgenetic AlopeciaImmunologyJun 2026
NCT07439848Umbilical Cord-Mesenchymal Stem Cell (UC-MSC)Phase 1Acute Respiratory Distress SyndromeRespiratoryDec 2026
NCT07439848UC-MSC and SecretomePhase 1Acute Respiratory Distress SyndromeRespiratoryDec 2026
NCT04314687Umbilical Cord Mesenchymal Stem Cells (UC-MSCs)Phase 1Cerebral PalsyNeurologyDec 2026
NCT04314687Conditioned MediumPhase 1Cerebral PalsyNeurologyDec 2026
NCT07396155Umbilical Cord Mesenchymal Stem Cells (UC-MSCs)Phase 1Diabetic Nephropathy Type 2GenitourinaryJul 2027
NCT07441226Umbilical Cord Mesenchymal Stem Cells (UC-MSCs)Phase 2Chronic Obstructive Pulmonary Disease (COPD)RespiratoryDec 2027

Targets

No annotated target.

Companies with the same targets

–

Programs group the company's trials by drug; the target and mechanism come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood, shown as a band with its track record, is in the app.